News + Resources
The Legislative Pillars Supporting Innovation & Access in the Life Sciences Ecosystem
For nearly four decades, policymakers have prioritized bipartisan policies that incentivize investment in groundbreaking medical research – aiming to make new innovations accessible for millions of Americans.
Life Sciences Companies Leverage M&A, Specialized Expertise to Advance Biopharmaceutical Breakthroughs
Over the past several decades, the U.S. life sciences ecosystem has emerged as a global leader in innovation with more than 2,300 biopharmaceutical companies spanning every state. Pro-innovation mergers and acquisitions (M&A) have been a critical component of the...
Life Sciences Mergers and Acquisitions: A Vital Bridge Across the “Valley of Death”
Every day, life sciences innovators discover promising new therapies with the potential to transform our approach to treating life-altering or life-threatening diseases. But what lies between these initial discoveries and an FDA-approved treatment reaching patients is...
M&A Provides Vital Bridge for Life Science Innovation Amid Economic Headwinds, Market Demands
In one of the more challenging investment economies in decades, life science innovators are increasingly forced to face difficult economic headwinds and market demands in their pursuit of breakthrough treatments and cures.
In Case You Missed It: American Enterprise Institute Panelists Weigh in on FTC & DOJ’s Flawed Approach to Merger Enforcement
Following the public comment period on the FTC and DOJ's proposed merger guidelines, leading antitrust experts and economists expressed significant concerns about the dramatic shift in competition policy that the proposal represents. In a recent panel discussion...